Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA libraryBy entering, you confirm the statements above are true. For laboratory research use only. Not for human or veterinary use. These products have not been evaluated by the U.S. Food and Drug Administration. Full Research Agreement & Waiver. (opens in a new tab)
Not a researcher? Exit
Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA libraryPackage image for the selected configuration.
A melanocortin-receptor agonist research peptide in an exact 10 mg configuration.
The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
The published laboratory report covers this exact lot.
Open the PDF to read every page in the lot-specific report.
We show no purity, identity, content, or contaminant result until a lot-specific report is available.
The selected literature uses PT-141 and bremelanotide for the named research compound and describes melanocortin-receptor pharmacology and a controlled clinical-response study. Those papers concern their own study material and protocol.
Stack Research supplies this product only for lawful in-vitro laboratory or analytical research. The independent literature linked on this page does not test this vial, and it provides no instructions for human or veterinary use.
The configuration selected above controls the exact SKU, package image, and lot report shown on this page.
This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.
The publications below discuss PT-141 or bremelanotide research. Only the lot report above evaluates the Stack Research product.
A paper's findings do not establish the identity, purity, safety, or intended use of this product.
Search PubMed for PT-141 (opens in a new tab)The selected literature uses PT-141 and bremelanotide for the named research compound. It discusses melanocortin-receptor pharmacology and a controlled human response study.
The publications below discuss PT-141 or bremelanotide research. Only the lot report above evaluates the Stack Research product.
Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.
The selected literature uses both PT-141 and bremelanotide for the named research compound.
The sources include a compound review and a controlled human response study. Neither provides lot-specific evidence for this product.
A current lot report covers exact SKU STK-P41, lot 1250, from Accumark Labs.
Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.
No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.
The publications below discuss PT-141 or bremelanotide research. Only the lot report above evaluates the Stack Research product.
No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.
Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.
Browse other products currently listed in the Stack Research catalog.
GLP-1 (SE)
Research peptides · 5 mg / 10 mg View product
GLP-2 (TZ)
Research peptides · 10 mg / 30 mg View product
GLP-3 (RT)
Research peptides · 10 mg / 30 mg View product
BPC-157
Research peptides · 5 mg / 10 mg View product
TB-500
Research peptides · 10 mg View product
TA-1 (Thymosin Alpha-1)
Research peptides · 10 mg View product
Sermorelin
Research peptides · 5 mg View product
Tesamorelin
Research peptides · 10 mg View product
Send the exact SKU and lot so support can trace the applicable product record.